Evidence map›Paper›PMID 38440702›Full record

ArticleIJU case reports2024

Robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using the novel surgical robot platform, hinotori: Initial experience with two cases.

Daisuke Motoyama, Yuto Matsushita, Hiromitsu Watanabe, Keita Tamura, Atsushi Otsuka, Masato Fujisawa, Hideaki Miyake

Open access · goldAbstract readCase Reports
In one paragraph

Article in IJU case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Daisuke MotoyamaDepartment of Urology Hamamatsu University School of Medicine Hamamatsu Japan.ORCID https://orcid.org/0000-0002-5315-3874
Yuto MatsushitaDepartment of Urology Hamamatsu University School of Medicine Hamamatsu Japan.ORCID https://orcid.org/0000-0002-8159-9793
Hiromitsu WatanabeDepartment of Urology Hamamatsu University School of Medicine Hamamatsu Japan.
Keita TamuraDepartment of Urology Hamamatsu University School of Medicine Hamamatsu Japan.
Atsushi OtsukaDepartment of Urology Hamamatsu University School of Medicine Hamamatsu Japan.
Masato FujisawaDivision of Urology Kobe University Graduate School of Medicine Kobe Japan.
Hideaki MiyakeDepartment of Urology Hamamatsu University School of Medicine Hamamatsu Japan.
Hamamatsu University School of Medicine · JPKobe University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: A newly developed surgical robot system, hinotori, with various unique advantages has been in clinical use in Japan; however, there have not been any studies of robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using hinotori. Case presentation: We describe two male patients aged 67 and 76 years old with right renal cell carcinoma and a level II and I inferior vena cava tumor thrombus, respectively, undergoing robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using hinotori. Both operations were successfully completed with a purely robotic procedure without any major perioperative complications, resulting in the following findings: time using robotic system, 158 and 156 min; total operative time, 228 and 214 min; estimated blood loss, 535 and 200 mL, respectively. Conclusion: Based on our first experience, robot-assisted radical nephrectomy and inferior vena cava tumor thrombectomy using hinotori may be an effective treatment for renal cell carcinoma with inferior vena cava tumor thrombus ≤level II.

Indexed as

hinotoriinferior vena cava tumor thrombectomyrenal cell carcinomarobot‐assisted radical nephrectomy

Identifiers

PMID38440702
PMCPMC10909141
OpenAlexW4388935049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.